REFERENCIAS

1. Jasso GL, Vargas OA, Villegas SR. Sindrome de dificultad respiratoria. En: Arellano PM, ed. Cuidados intensivos en pediatria. 3a edici6n. Mexico: Interamericana McGraw-Hill, 1994: 206-219.

2. Hodson WA. Normal and abnormal structural development of the lung. En: Polin RA, ed. Fetal and neonatal physiology.Philadelphia: WB Saunders, 1992: 771-780.

3. Zeltner TB, Burri PH. The postnatal development and growth of the human lung. I. Morphometry. RespirPhysiol 1987; 67:247-250.

4. Zeltner TB, Burri PH. The postnatal development and growth of the human lung. II. Morphology. Respir Physiol 1987; 67:269-272.

5. Boyden EA. Development and growth of the airways. En: Hodson WA, ed. Development of the lung. New York: Marcer Dekker, 1977: 3-35

6. Haworth SG. Development of the pulmonary circulation. En: Polin RA, ed. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 671-678.

7. Zetter BR. Angiogenesis: State of the art. Chest 1988;93: 1595.

8. Hall S, Haworth SG. Conductingpulmonary arteries: Structural adaptation to extrauterine life. Cardiovasc Res 1986; 21: 208-210.

9. Mathew R. Metabolic aspects. En: Polin RA, ed. Fetal and neonatal physiology. Philadelphia: WB Saunders,1992: 678-681.

10. Smith CA, Nelson NM. The physiology of the newborn infant. 4a ed. Springfield, Illinois: Charles C. Thomas Publisher,1976.

11. Bland RD. Formation of fetal lung liquid and its removal near birth. En: Polin RA, ed. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 782-788.

12. Avery ME, Fletcher BD. The lung and its disorders in the newborn infant. 5a ed. Philadelphia: WB Saunders, 1992.

13. Rigatto H. Control of breathing in fetal life and onset and control of breathing in the neonate. En: Polin RA, ed. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 790-799.

14. Jasso GL. Función pulmonar. En: Jasso GL, ed. Neonatologia practica.4a ed. Mexico: El Manual Moderno, 1995: 104-112.

15. Bosma JF. Anatomy of the infant head. Baltimore: Johns Hopkins University Press, 1986: 21-30.

16. Harding R. Perinatal development of laryngeal function. J Dev Physiol 1984; 6:249-252

17. Mathew OP. Pharyngeal airway obstruction in preterm infants during mixed and obstructive apnea. J Pediatr 1982; 100:964-967.

18. Rodenstein DO. Infants are not obligatory nasal breathers. Am Rev Respir Dis 1985; 131: 343-347.

19. Duara S. Structure and function of the upper airway in neonates. En: Polin RA, ed. Fetal and neonatal physiology. Philadelpia: WB Saunders,1992: 823-828.

20. Woodrum D. Respiratory muscles. En: Polin RA, ed. Fetal and neonatal physiology. Philadelphia: WB Saunders,1992:829-839.

21. Bancalari E. Pulmonary function testing and other diagnostic laboratory procedures in neonatal pulmonary care. En: Thibeault DW, Gary GA, ed. Neonatal pulmonary care. 2a ed. East Norwalk CT: Appleton-Century-Crofts, 1986: 195-234.

22. McCann EM. Pulmonary function in the sick newborn infant. Pediatr Res 1987; 21:213-218.

23. Bhutani V, Abbasi S. Evaluation of pulmonary function in the neonate. En: Polin RA, ed. Fetal and neonatal physiology. Philadelphia: WB Saunders,1992:853-871.

24. Whitsett JA. Composition of pulmonary surfactant lipids and proteins. En: Polin RA, ed. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 941-948.

25. Possmayer F. Biophysical activities of pulmonary surfactant. En: Polin RA, ed.Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 949-961.

26. Rooney SA. Regulation of surfactant associated phospholipid synthesis and secretion. En: Polin RA, ed. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 971-985

27. Engle WD. Diuresis and respiratory distress syndrome: Physiologic mechanisms and therapeutic implications. J Pediatr 1983;102:912-915.

28. Jasso GL, Falc6n DO, Casimiro PB. Velocidad de filtraci6n glomerular en neonatos con sindrome de insuficiencia respiratoria idiopatica. Bol Med Hosp Infant Mex 1977;34:271-273.

29. Vargas OA, Contreras MG, Dominguez CC,Jasso GL, Chavez NF. Alfa-1-antitripsina en neonatos con sindrome de insuficiencia respiratoria idiopatica. Bol Med Hosp Infant Mex 1978; 35:703-710.

30. Jasso GL, Contreras G, Puente BE, Romero VG. Actividad inhibitoria de la alfa-1-antitripsina en ninos con sindrome de insuficiencia respiratoria idiopatica. Arch Invest Med Mex 1979;10:1-6.

31. Jasso GL, Contreras G, Puente BE, Romero VG. Efectos del pH sobre la actividad de la alfa-1-antitripsina en ninos prematuros con sindrome de insuficiencia respiratoria idiopatica. Arch InvestMed Mex 1979;10:7.

32. Jasso GL. Neonatologia practica. 4a ed. Mexico: El Manual Moderno, 1995.

33. Bhutani VK. Differential diagnosis of neonatal respiratory disorders. En: Spitzer AR, ed. Intensive care of the fetus and neonate. St Louis: Mosby-Year Book Inc. 1994.

34. Jasso GL, Vargas OA. El indice timotoracico y su utilidad en el diagnostico del sindrome de dificultad respiratoria. Bol Med Hosp Infant Mex 1981;38:49-54

35. Jasso GL, Vargas OA, Diaz del Castillo E. Insuficiencia respiratoria neonatal. I. Importancia del componente metab61ico. Rev Med I.M.S.S. 1976; 15:15-18.

36. López AJU. Evaluaci6n de la función miocardica en el recien nacido. En: Jasso GL. Neonatologia. Temas de Pediatria. Mexico: Interamericana-McGraw-Hill, 1996; 147-159.

37. Segura AMA, Enriquez RR. Medición de los plexos coroides de los ventriculos laterales en neonatos de termino por ultrasonido. Bol Med Hosp Infant Mex 1990; 47:382.

38. Segura AMA, Farias GL, Sollano CL, Carsi BE. Medición de los plexos coroides de los ventriculos laterales en neonatos de pretermino mediante ultrasonido. Rev Mex Pediatr 1992; 59:106.

39. Jasso GL. Insuficiencia respiratoria en niño con sindrome de dificultad respiratoria grave. En: Jasso GL. ed, Neonatologia practica. 4a ed. Mexico: El Manual Moderno, 1995:290-291

40. Jasso GL. Metodos de oxigenaci6n y ventilación neonatal. En: Jasso GL. ed, Neonatologia practica. 4a ed. Mexico, 1995:292-305.

41. The HIFI Study Group. High-fr oscillatory ventilation compar conventional mechanical ventilati treatment of respiratory failure in infants. N Engl J Med 1989; 320

42. Poland RL. Recommendation o corporeal membrane oxygenatiotrics 1990; 85:618-619.

43. Kanto WP. A decade of experience with neonatal extracorporeal membrane oxygenation. J Pediatr 1994; 124:335-345.

44. Greenspan JS, Wolfson MR, R. SD, Shaffer TH. Liquid ventilation of human pretern neonates. J Pediatr 117: 106-111.

45. Fuhrman BP. Perfluorocarbo ventilation: The first human trial. 1990; 117: 73-74.

46. Wolfson MR, Greenspan JS, Sh Pulmonary administration of vasoactive substances by perfluorochemic ventilation. Pediatrics 1996; 97:449-455

47. Stark AR. Inhaled nitric oxide por persistent pulmonary hypertension of the newborn: Implications and strategy for future "High-Tech" neonatal clinical trials Pediatrics 1995; 96:1147-1151.

48. Abman SH, Kinsella JP. Inhaled nitrid oxide for persistent pulmonar hypertension of the newborn: The phsyology matters. Pediatrics 1995;96:1153-1155

49. Pezzoti RMA, Sollano CL. Controversias en relacion con el uso del agente tensoactivo pulmonar. En: Jasso GL, ed. Neonatología México: Interamericana-McGraw-Hill, 1996: 135-146.

50. Shapiro DL. Surfactant replacement therapy. En: Polin RA, ed. Fetal and neonatal physiology. Philadelphia: WB Saunders, 1992: 1007-1013.

51. Raju TNK. Pulmonary hemorrhage and exogenous surfactant therapy: A metanalysis. J Pediatr 1993; 123:603-610.

FE DE ERRATAS En el PAC P-1 A-4 de SIDA, existe un error en la respuesta de la pregunta No. 10 donde dice "10 b" debiendo ser "10 c", ya que la vacuna contra poliomielitis de virus vivos (Sabin) no está indicada en ninos con SIDA.